← Leaderboards
Leonard Bruce Saltz
Sloan-Kettering Institute For Cancer Res
$258,040
Attributed
$258,040
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$258,040 · 1
By mechanism
R01$258,040 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Joseph Rocco Bertino$26,398,552
- David R Spriggs$13,987,182
- Jason A Koutcher$20,695,436
- David A Scheinberg$21,198,583
- David W Golde$3,118,085
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsClinical ResearchClinical Trial Phase IColorectal NeoplasmsCombination Cancer TherapyDrug Screening /EvaluationEnzyme ActivityFluorouracilGene ExpressionHuman Genetic Material TagHuman SubjectHuman Therapy EvaluationIrinotecanLeucovorinMetastasisNeoplasm /Cancer ChemotherapyNeoplasm /Cancer PharmacologyPentosyltransferasePharmacokineticsPrognosisThymidylate SynthaseTopotecan